CNS Pharmaceuticals, Inc. (CNSP) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate CNS Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
47/100
Fair
Valuation Metrics
P/E Ratio
-1.54
Weak
WeakModerateStrong
P/B Ratio
3.71
Strong
WeakModerateStrong
Earnings Yield
-64.83%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
-240.55%
Weak
WeakModerateStrong
Operating Margin
N/A%
Net Profit Margin
N/A%
Growth Indicators
Revenue Growth
N/A%
Net Income Growth
21.18%
Strong
WeakModerateStrong
EPS Growth
35.22%
Strong
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
3.43
Strong
WeakModerateStrong
Quick Ratio
3.43
Strong
WeakModerateStrong
Asset Turnover
0.00x
Weak
WeakModerateStrong
Inventory Turnover
0.00x
Weak
WeakModerateStrong